IL236084A0 - Compounds of amides of 2-amino-4-arylthiazole and their salts - Google Patents
Compounds of amides of 2-amino-4-arylthiazole and their saltsInfo
- Publication number
- IL236084A0 IL236084A0 IL236084A IL23608414A IL236084A0 IL 236084 A0 IL236084 A0 IL 236084A0 IL 236084 A IL236084 A IL 236084A IL 23608414 A IL23608414 A IL 23608414A IL 236084 A0 IL236084 A0 IL 236084A0
- Authority
- IL
- Israel
- Prior art keywords
- amides
- salts
- amino
- arylthiazole compounds
- arylthiazole
- Prior art date
Links
- 150000001408 amides Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1687MU2012 | 2012-06-08 | ||
| US201261665282P | 2012-06-27 | 2012-06-27 | |
| IN3519MU2012 | 2012-12-13 | ||
| US201261748016P | 2012-12-31 | 2012-12-31 | |
| PCT/IB2013/054703 WO2013183035A2 (en) | 2012-06-08 | 2013-06-08 | Amides of 2-amino-4-arylthiazole compounds and their salts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL236084A0 true IL236084A0 (en) | 2015-02-01 |
Family
ID=54193746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL236084A IL236084A0 (en) | 2012-06-08 | 2014-12-04 | Compounds of amides of 2-amino-4-arylthiazole and their salts |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US9458173B2 (enExample) |
| EP (1) | EP2858999B1 (enExample) |
| JP (1) | JP5989900B2 (enExample) |
| KR (1) | KR20150015488A (enExample) |
| CN (1) | CN104350058A (enExample) |
| AP (1) | AP3546A (enExample) |
| AU (1) | AU2013273118B2 (enExample) |
| BR (1) | BR112014029155A2 (enExample) |
| CA (1) | CA2873570C (enExample) |
| CL (1) | CL2014003317A1 (enExample) |
| EA (1) | EA031334B1 (enExample) |
| HK (1) | HK1207643A1 (enExample) |
| IL (1) | IL236084A0 (enExample) |
| IN (1) | IN2014MN02467A (enExample) |
| MX (1) | MX354014B (enExample) |
| MY (1) | MY165622A (enExample) |
| NZ (1) | NZ701721A (enExample) |
| PE (1) | PE20142306A1 (enExample) |
| PH (1) | PH12014502685B1 (enExample) |
| SG (1) | SG11201408093PA (enExample) |
| WO (1) | WO2013183035A2 (enExample) |
| ZA (1) | ZA201500082B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR091279A1 (es) | 2012-06-08 | 2015-01-21 | Gilead Sciences Inc | Inhibidores macrociclicos de virus flaviviridae |
| CA2875692A1 (en) | 2012-06-08 | 2013-12-12 | Selcia Limited | Macrocyclic inhibitors of flaviviridae viruses |
| CN105307642A (zh) | 2013-06-20 | 2016-02-03 | 格兰马克药品股份有限公司 | 包含trpa1拮抗剂的纳米颗粒制剂 |
| JP6573968B2 (ja) * | 2014-08-11 | 2019-09-11 | ハイドラ バイオサイエンシズ インコーポレイテッドＨｙｄｒａ Ｂｉｏｓｃｉｅｎｃｅｓ，Ｉｎｃ． | ＴＲＰＣ５調節因子としての、精神神経障害の処置のためのチエノおよびフロ［２，３−ｄ］ピリミジン−２，４［１Ｈ，３Ｈ］−ジオン誘導体 |
| US20190175599A1 (en) * | 2014-09-16 | 2019-06-13 | Glemark Pharmaceuticals S.A. | Trpa1 antagonist for the treatment of pain associated to diabetic neuropathic pain |
| TW202321229A (zh) | 2021-08-18 | 2023-06-01 | 美商富曼西公司 | 殺真菌的取代的雜環化合物 |
| CN114671875A (zh) * | 2022-04-27 | 2022-06-28 | 成都施贝康生物医药科技有限公司 | 新型二氢嘧啶类化合物、异构体或盐及其制备方法和用途 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2248231A1 (de) | 1972-10-02 | 1974-04-11 | Basf Ag | 3-aminoisothiazolo eckige klammer auf 3,4-d eckige klammer zu pyrimidine |
| SE9701398D0 (sv) | 1997-04-15 | 1997-04-15 | Astra Pharma Prod | Novel compounds |
| ES2193839B1 (es) | 2001-06-22 | 2005-02-16 | Almirall Prodesfarma, S.A. | Nuevos derivados de 6-fenildihidropirrolpirimidindiona. |
| AU2003253165A1 (en) | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Pyrimidine fused bicyclic metalloproteinase inhibitors |
| US6890923B2 (en) | 2002-12-16 | 2005-05-10 | Astrazeneca Ab | Compounds |
| US7465581B2 (en) | 2002-12-18 | 2008-12-16 | The Scripps Research Institute | ANKTM1, a cold-activated TRP-like channel expressed in nociceptive neurons |
| EP1657238A4 (en) * | 2003-08-22 | 2008-12-03 | Takeda Pharmaceutical | CONDENSATE PYRIMIDINE DERIVATIVE AND ITS USE |
| JP2007522214A (ja) | 2004-02-11 | 2007-08-09 | スミスクライン・ビーチャム・コーポレイション | Ｐｔｈアゴニスト |
| US20070196866A1 (en) | 2004-03-13 | 2007-08-23 | Irm Llc | Modulators of ion channel trpa1 |
| WO2006083005A1 (ja) | 2005-02-03 | 2006-08-10 | Takeda Pharmaceutical Company Limited | 縮合ピリミジン誘導体およびその用途 |
| CA2617788A1 (en) | 2005-08-04 | 2007-02-15 | Apogee Biotechnology Corporation | Sphingosine kinase inhibitors and methods of their use |
| US20070105920A1 (en) | 2005-11-08 | 2007-05-10 | Akzo Nobel N.V. | 2-(Benzimidazol-1-Yl)-N-(4-phenylthiazol-2-yl) acetamide derivatives |
| CN101384261B (zh) * | 2005-12-22 | 2011-12-07 | 海德拉生物科学公司 | 治疗疼痛的组合物 |
| CN101454318A (zh) * | 2006-03-22 | 2009-06-10 | 阿斯利康(瑞典)有限公司 | 吡啶并嘧啶衍生物及其作为pde4抑制剂的用途 |
| TW200800997A (en) | 2006-03-22 | 2008-01-01 | Astrazeneca Ab | Chemical compounds |
| JP2011201776A (ja) | 2008-07-23 | 2011-10-13 | Mochida Pharmaceut Co Ltd | ヘテロシクリデン−ｎ−（３，４−ジヒドロ−２（１ｈ）−キナゾリノン−５−イル）アセトアミド誘導体 |
| AR065081A1 (es) | 2007-01-29 | 2009-05-13 | Xenon Pharmaceuticals Inc | Compuestos de quinazolinona y pirimidona fusionados y composicion farmaceutica |
| WO2009002933A1 (en) | 2007-06-22 | 2008-12-31 | Hydra Biosciences, Inc. | Methods and compositions for treating disorders |
| WO2010004390A1 (en) * | 2008-06-17 | 2010-01-14 | Glenmark Pharmaceuticals, S.A. | Quinazoline dione derivatives as trpa1 modulators |
| WO2009158719A2 (en) | 2008-06-27 | 2009-12-30 | Hydra Biosciences, Inc. | Methods and compositions for treating disorders |
| US8623880B2 (en) | 2009-03-23 | 2014-01-07 | Glenmark Pharmaceuticals S.A. | Fused pyrimidine-dione derivatives as TRPA1 modulators |
| ES2424340T3 (es) | 2009-03-23 | 2013-10-01 | Glenmark Pharmaceuticals S.A. | Derivados de isotiazolo-pirimidindiona como moduladores de TRPA1 |
| AU2010227225A1 (en) * | 2009-03-23 | 2011-09-15 | Glenmark Pharmaceuticals, S.A. | Furopyrimidinedione derivatives as TRPA1 modulators |
| AU2010227245B2 (en) | 2009-03-23 | 2015-09-10 | Glenmark Pharmaceuticals S.A. | Fused pyrimidine-dione derivatives as TRPA1 modulators |
| AU2011346763B2 (en) | 2010-12-20 | 2016-01-07 | Glenmark Pharmaceuticals S.A. | 2-amino-4-arylthiazole compounds as TRPA1 antagonists |
-
2013
- 2013-06-08 HK HK15108333.2A patent/HK1207643A1/xx unknown
- 2013-06-08 MY MYPI2014003389A patent/MY165622A/en unknown
- 2013-06-08 IN IN2467MUN2014 patent/IN2014MN02467A/en unknown
- 2013-06-08 AP AP2014008076A patent/AP3546A/xx active
- 2013-06-08 EP EP13742279.6A patent/EP2858999B1/en active Active
- 2013-06-08 BR BR112014029155A patent/BR112014029155A2/pt not_active Application Discontinuation
- 2013-06-08 US US14/402,608 patent/US9458173B2/en not_active Expired - Fee Related
- 2013-06-08 MX MX2014014482A patent/MX354014B/es active IP Right Grant
- 2013-06-08 SG SG11201408093PA patent/SG11201408093PA/en unknown
- 2013-06-08 AU AU2013273118A patent/AU2013273118B2/en not_active Ceased
- 2013-06-08 JP JP2015515642A patent/JP5989900B2/ja not_active Expired - Fee Related
- 2013-06-08 KR KR1020147033855A patent/KR20150015488A/ko not_active Abandoned
- 2013-06-08 CN CN201380030184.XA patent/CN104350058A/zh active Pending
- 2013-06-08 WO PCT/IB2013/054703 patent/WO2013183035A2/en not_active Ceased
- 2013-06-08 CA CA2873570A patent/CA2873570C/en active Active
- 2013-06-08 PE PE2014002226A patent/PE20142306A1/es not_active Application Discontinuation
- 2013-06-08 NZ NZ701721A patent/NZ701721A/en not_active IP Right Cessation
- 2013-06-08 EA EA201492054A patent/EA031334B1/ru unknown
-
2014
- 2014-12-02 PH PH12014502685A patent/PH12014502685B1/en unknown
- 2014-12-04 CL CL2014003317A patent/CL2014003317A1/es unknown
- 2014-12-04 IL IL236084A patent/IL236084A0/en unknown
-
2015
- 2015-01-07 ZA ZA2015/00082A patent/ZA201500082B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA201500082B (en) | 2015-12-23 |
| AU2013273118A1 (en) | 2014-11-27 |
| EP2858999A2 (en) | 2015-04-15 |
| EP2858999B1 (en) | 2017-05-10 |
| EA201492054A1 (ru) | 2016-08-31 |
| SG11201408093PA (en) | 2015-01-29 |
| WO2013183035A2 (en) | 2013-12-12 |
| CN104350058A (zh) | 2015-02-11 |
| AP2014008076A0 (en) | 2014-11-30 |
| BR112014029155A2 (pt) | 2017-06-27 |
| MX354014B (es) | 2018-02-08 |
| NZ701721A (en) | 2016-03-31 |
| KR20150015488A (ko) | 2015-02-10 |
| PE20142306A1 (es) | 2015-01-16 |
| PH12014502685A1 (en) | 2015-01-26 |
| AP3546A (en) | 2016-01-14 |
| AU2013273118B2 (en) | 2015-11-05 |
| MY165622A (en) | 2018-04-18 |
| JP5989900B2 (ja) | 2016-09-07 |
| EA031334B1 (ru) | 2018-12-28 |
| US9458173B2 (en) | 2016-10-04 |
| JP2015520183A (ja) | 2015-07-16 |
| CA2873570C (en) | 2016-11-01 |
| CA2873570A1 (en) | 2013-12-12 |
| WO2013183035A3 (en) | 2014-02-27 |
| IN2014MN02467A (enExample) | 2015-07-10 |
| CL2014003317A1 (es) | 2015-02-13 |
| US20150111038A1 (en) | 2015-04-23 |
| HK1207643A1 (en) | 2016-02-05 |
| MX2014014482A (es) | 2015-06-05 |
| PH12014502685B1 (en) | 2015-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201504049VA (en) | Compounds and their methods of use | |
| ZA201502503B (en) | Hppd variants and methods of use | |
| HUE044300T2 (hu) | 3-amino-cikloalkil-vegyületek, mint ROR-GAMMA-T inhibitorok és alkalmazásuk | |
| ZA201405253B (en) | Heterocyclic compounds and methods for their use | |
| ZA201406082B (en) | Use of ccr3-inhibitors | |
| PL2807153T3 (pl) | Związki heterocykliczne i sposoby ich zastosowania | |
| PL2807171T3 (pl) | Związki heterocykliczne i sposoby ich stosowania | |
| AP3611A (en) | Heterocyclic compounds and their uses | |
| ZA201500082B (en) | Amides of 2-amino-4-arylthiazole compounds and their salts | |
| ZA201408128B (en) | Etract of greyia radlkoferi and use thereof | |
| ZA201501374B (en) | Amine salt and crystals thereof | |
| ZA201308872B (en) | Use of a dinitromethane salt | |
| GB201213726D0 (en) | Novel compounds and their use |